CarolinaEscobarMD

Oncology • Dallas, TX

Physician

Join to view full profile

Dr. Escobar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Escobar's full profile

Already have an account?

Office
3410 Worth St Ste 300
Dallas, TX 75246
Phone+1 214-370-1000

Fax+1 214-370-1585

Education & Training

Louisiana State University School of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2011
Louisiana State University School of MedicineResidency, Internal Medicine, 2005 - 2008
Pontifical Bolivarian UniversityClass of 2003

Certifications & Licensure

TX State Medical License 2011 - 2026
NJ State Medical License 2016 - 2019
LA State Medical License 2008 - 2013
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Safety Evaluation of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation Start of enrollment: 2017 Feb 08
Completed
Phase 1

Publications & Presentations

PubMed

48 citations
Two closely related members of Arabidopsis 13‐lipoxygenases (13‐LOXs), LOX3 and LOX4, reveal distinct functions in response to plant‐parasitic nematode infection
Rachel Ozalvo, Javier Cabrera, Carolina Escobar, Shawn A. Christensen, Eli J. Borrego
Molecular Plant Pathology. 2014-05-01
42 citations
Altered sucrose synthase and invertase expression affects the local and systemic sugar metabolism of nematode-infected Arabidopsis thaliana plants
Susana Cabello, Cindy Lorenz, Sara Crespo, Javier Cabrera, Roland Ludwig
Journal of Experimental Botany. 2014-01-01
16 citations
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study.
Gareth P Gregory, Shaji Kumar, Ding Wang, Daruka Mahadevan, Patricia Walker
Blood Advances. 2022-02-22

Press Mentions

Employer Direct Healthcare Welcomes City of Hope as One of the First National Cancer Institute-Designated Comprehensive Cancer Centers to Join Its Provider Network Supporting a Groundbreaking Oncology SolutionJanuary 20th, 2022